Brief: Akari Therapeutics Provides Corporate Update
04/12/2025 14:04
Dec 4 (Reuters) - Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS PROVIDES CORPORATE UPDATE AND HIGHLIGHTS ITS ADC PAYLOAD INNOVATION EXPECTED TO DRIVE VALUE IN NEW CEO CORNER SEGMENT Source text: ID:nGNX6SsQXC Further company coverage: AKTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics